Sourced from:Manufacturer Authorized Distributor
Quick Summary
Mabura 40mg Pen
Last updated on 06 Nov 2026 | 04:59 AM (IST)
₹8333
MRP: ₹25781.25
(You Save ₹17448.25)
1 PREFILLED PEN(s) OF 0.8ML
Sourced from:Manufacturer Authorized Distributor
Mabura 40mg Pen
Salt Composition
ADALIMUMABMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
68% OFF
₹8333
MRP: ₹25,781.25
Inclusive of all taxes
68% Off
Salt Composition
ADALIMUMABMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Azimbra 40mg Injection
ABBOTT
₹ 5512.00/injection
33% cheaper
Exemptia 40mg Injection
ZYDUS CADILA
₹ 5682.00/injection
31% cheaper
Mabura 40mg Injection PFS
HETERO HEALTHCA...
₹ 5918.00/injection
28% cheaper
Adlumab 40mg Injection
RPG LIFE SCIENC...
₹ 6100.00/injection
26% cheaper
Better Service Satisfied Customers
Introduction
Mabura 40mg Pen contains the active ingredient adalimumab, a TNF inhibitor widely used in rheumatoid arthritis injection treatment. It is prescribed alone or along with other therapies to reduce joint pain, swelling, and stiffness in autoimmune conditions. Many patients check the Adalimumab injection price 40mg or compare Adalimumab biosimilar brands in India before beginning therapy due to long-term treatment requirements. This medicine is also helpful in improving symptoms of juvenile idiopathic arthritis, enthesitis-related arthritis, and is considered an effective injection for ankylosing spondylitis when spine inflammation is present. People often explore the Mabura 40mg Pen price and Mabura 40mg Pen review before choosing this biosimilar.
Mabura is also indicated for psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, and non-infectious uveitis. Patients using this medicine at home often follow Mabura 40mg subcutaneous injection instructions to ensure safe and correct administration. The Mabura 40mg dosage frequency is usually once every two weeks, depending on the physician’s advice. Individuals who prefer online access sometimes search for Mabura 40mg Pen buy online options, especially through a certified Mabura 40mg Pen wholesaler India. The product is manufactured by Mabura 40mg Pen manufacturer Hetero, a well-known Indian pharmaceutical company.
Avoid using this medicine if you are allergic to its ingredients. It is not advised in active tuberculosis, serious infections, or moderate to severe heart failure. Inform your doctor if you have lung, liver, kidney problems, or ongoing infections. Pregnant women or those planning pregnancy should seek medical advice before starting treatment. The Mabura 40mg Pen uses and side effects must always be reviewed with a healthcare professional.
Uses
Polyarticular juvenile idiopathic arthritis
Enthesitis-related arthritis
Ankylosing spondylitis
Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
Psoriatic arthritis
Plaque psoriasis
Hidradenitis suppurativa
Crohn’s disease
Ulcerative colitis
Non-infectious uveitis
How Mabura 40mg pen works
The active ingredient in this medicine is a human monoclonal antibody. Monoclonal antibodies are proteins that attach to a specific target. The target of Mabura 40mg pen is a protein called tumor necrosis factor (TNFα), which is involved in the immune (defense) system and at increased levels in the inflammatory diseases. By attaching to TNFα, Humira decreases inflammation in these diseases.
Interaction of Mabura 40mg pen with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccines, nutritional and vitamin supplements, and herbal products. Certain medications interact with Mabura 40mg pen and reduce its effectiveness by causing undesirable side effects.
1. Live Vaccines
Live vaccines (such as MMR, varicella, and intranasal flu vaccine) should be avoided.
Why? Mabura lowers immunity, and live vaccines can cause infections.
2. Other Immunosuppressants
Drugs like azathioprine, cyclosporine, or methotrexate may increase the risk of infections when taken with Mabura.
Why? Both suppress the immune system, making the body more vulnerable.
3. Biologic Agents for Autoimmune Diseases
Medicines like infliximab, etanercept, or rituximab should not be combined.
Why? Using multiple biologics increases the chance of serious infections and immune-related side effects.
4. Blood Thinners (e.g., warfarin)
Mabura may affect how the body responds to anticoagulants.
Why? It can slightly alter clotting factors or increase bleeding risk in some patients.
Storage conditions
Store in a refrigerator (2°C – 8°C).
Do not freeze.
Protect the medicine from light and excessive moisture.
Keep the medicine out of reach of children and pets
How to use Mabura 40mg pen
Your doctor will decide the dose, duration, and frequency of administration based on your disease condition, severity and other factors. Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
This medicine is to be administered by injection under the skin (subcutaneously). Your doctor or other healthcare professional will train you on how to use this injection. Do not self-administer this injection until you get trained. Your doctor will decide the dose, duration, and frequency of administration based on your disease condition, severeity and other factors.
Safety Advice for Mabura 40mg Injection
Breast Feeding
Mabura 40mg pen can be used during breastfeeding. However, inform your physician if you are breastfeeding.
Alcohol
It is unknown whether consuming alcohol is safe during treatment with Mabura 40mg pen. Consult your doctor for more advice.
Liver
Mabura 40mg pen should be taken cautiously in patients with liver problems. Inform your physician if you have any liver diseases before initiating the treatment.
Lungs
Mabura 40mg pen should be taken cautiously in patients with lung problems. Inform your physician if you have any lung diseases before initiating the treatment.
Driving
Mabura 40mg pen may have a small effect on your ability to drive, cycle or use machines. Room spinning sensation and vision disturbances may occur after taking this medicine
Pregnancy
Do not take Mabura 40mg pen during pregnancy unless your doctor says. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for at least 5 months after the last dose.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common
Injection site reactions
Rash
Headache
Sinusitis
Upper respiratory infections
Fever
Serious
Heart problems
Abnormal heart beat
Severe skin reactions
GI bleeding
Abnormal blood count values
Liver injury
Bone problems
Infections
Severe respiratory problems
Expert tips
Some vaccines may cause infections while using this medicine; consult your doctor before getting any vaccination.
Inform your doctor if you currently have or previously had hepatitis B, as this medicine may increase the risk of reactivation.
If you are instructed to take the medicine at home, ensure you fully understand how to give the injection before starting.
You will be guided on the appropriate body areas for injections; follow these instructions carefully.
Rotate injection sites each time to avoid irritation—keep a record of where each dose is given.
Avoid injecting into areas that are red, bruised, tender, swollen, or hardened.
If you miss a dose, take it as soon as you remember.
If it is nearly time for your next dose, skip the missed dose and continue your regular schedule.
Do not take extra doses to compensate for a missed one.
FAQs about Mabura 40mg Injection
Q1.
When can you expect Mabura 40mg pen to start showing effects?
The response to Mabura 40mg pen can vary among individuals and the condition being treated. Some individuals may experience improvement in symptoms within a few weeks, while others may take longer. It is important to follow the healthcare provider's instructions and allow sufficient time for the medication to take effect.
Q2.
Can Mabura 40mg pen increase the risk of infections?
Mabura 40mg pen may increase the risk of serious bacterial, viral, or fungal infections. It is essential to promptly report any signs of infection to a healthcare provider while taking this medicine. Inform your physician if you have or had any active infections.
Q3.
What are the common side effects of Mabura 40mg pen?
Common side effects of Mabura 40mg pen may include injection site reactions, such as pain, redness, or swelling. Other possible side effects include headaches, upper respiratory infections, nausea, and rash. Serious side effects are rare but can occur.
Q4.
What determines the duration of Mabura 40mg pen treatment?
The duration of Mabura 40mg pen treatment can vary depending on the individual's condition and response to the medication. In some cases, this medicine may be used as a long-term maintenance therapy, while treatment duration may be shorter in other situations. It is important to follow the healthcare provider's guidance regarding the appropriate duration of treatment.
Q5.
Can Mabura 40mg pen be used in individuals with kidney or liver impairment?
Mabura 40mg pen may require dosage adjustments or caution in individuals with kidney or liver impairment. Healthcare providers will assess the patient's situation and determine the appropriate dosage based on renal and hepatic function.
Fact Box
Molecule name | Adalimumab |
Therapeutic class | Antirheumatic agent, Monoclonal antibody |
Pharmacological class | TNF inhibitors |
Indications | 1. Rheumatoid arthritis 2. Polyarticular juvenile idiopathic arthritis 3. Enthesitis-related arthritis 4. Ankylosing spondylitis 5. Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis 6. Psoriatic arthritis 7. Plaque psoriasis 8. Hidradenitis suppurativa 9. Crohn’s disease 10. Ulcerative colitis 11. Non-infectious uveitis |
References
Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Immunosuppressants, Tolerogens, and Immunostimulants, 12th edition, 2011, 1018.
KD Tripathi, Essentials of Medical Pharmacology, Antirheumatoid and antigout drugs, 7th edition, 2013, 213.
AbbVie Ltd, Electronic medicines compendium (emc), [ Revised on April 2021] [ Accessed on July 2023], https://www.medicines.org.uk/emc/files/pil.2150.pdf
AbbVie Inc, US Food and Drug Administration, [ Revised on Feb 2021] [ Accessed on July 2023], https://www.rxabbvie.com/pdf/humira.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Karpagam A.
Pharm D

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 06 Nov 2026 | 04:59 AM (IST)

Want to know more?
Read Our Editorial Policy







